BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30229283)

  • 1. [Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
    Hirsch D; Gaiser T
    Pathologe; 2018 Dec; 39(Suppl 2):253-261. PubMed ID: 30229283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
    Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
    Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
    Hirsch D; Hardt J; Sauer C; Heselmeyer-Hadded K; Witt SH; Kienle P; Ried T; Gaiser T
    Mod Pathol; 2021 Jun; 34(6):1153-1166. PubMed ID: 33318582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
    Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
    Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Wanders LK; Cordes M; Voorham Q; Sie D; de Vries SD; d'Haens GRAM; de Boer NKH; Ylstra B; van Grieken NCT; Meijer GA; Dekker E; Carvalho B
    Inflamm Bowel Dis; 2020 Jan; 26(2):167-180. PubMed ID: 31372648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
    Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
    Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
    Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
    Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
    Bui VM; Mettling C; Jou J; Sun HS
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Matsumoto K; Urabe Y; Oka S; Inagaki K; Tanaka H; Yuge R; Hayashi R; Kitadai Y; Arihiro K; Shimamoto F; Tanaka S; Chayama K
    Inflamm Bowel Dis; 2021 Apr; 27(5):686-696. PubMed ID: 33089869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].
    Hirsch D
    Pathologe; 2019 Dec; 40(Suppl 3):232-238. PubMed ID: 31811372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.
    Rapozo DC; Grinmann AB; Carvalho AT; de Souza HS; Soares-Lima SC; de Almeida Simão T; de Paiva D; Abby F; Albano RM; Pinto LF
    Int J Colorectal Dis; 2009 Oct; 24(10):1141-8. PubMed ID: 19543899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.
    Lennerz JK; van der Sloot KWJ; Le LP; Batten JM; Han JY; Fan KC; Siegel CA; Srivastava A; Park DY; Chen JH; Sands BE; Korzenik JR; Odze RD; Dias-Santagata D; Borger DR; Khalili H; Iafrate AJ; Lauwers GY
    Int J Colorectal Dis; 2016 May; 31(5):973-982. PubMed ID: 27026089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
    Carethers JM; Jung BH
    Gastroenterology; 2015 Oct; 149(5):1177-1190.e3. PubMed ID: 26216840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    Ali H; Bitar MS; Al Madhoun A; Marafie M; Al-Mulla F
    PLoS One; 2017; 12(2):e0171690. PubMed ID: 28231327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.